Trial
NCT02090348
Study to Evaluate Fatigue in Participants With Relapsing Remitting Multiple Sclerosis When Treated With Dimethyl Fumarate
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Biogen
Collaborators
—
Condition
Relapsing-Remitting Multiple Sclerosis
Intervention
dimethyl fumarate
Why stopped
The study was withdrawn for business reasons. The decision to stop the TECNERGY study was not a result of any safety or efficacy concerns.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-09-07